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Abstract Adipocyte-epithelial cell interactions and their secre-
tions are critical determinants of mammary gland development.
In this present study, we examined the possible involvement of
leptin and its receptors in the process of mammogenesis/
lactogenesis. We demonstrated by reverse transcription and
polymerase chain reaction analysis that long and short forms of
leptin receptors were expressed in the ovine mammary gland
during pregnancy and lactation. Furthermore, quantitative
determinations, via ribonuclease protection assays, provided
evidence that the level of leptin receptor expression was greatest
during mid-pregnancy when active growth of the mammary gland
is initiated. Location of the leptin receptors, as determined by in
situ hybridization analysis, revealed that leptin receptor tran-
scripts were expressed specifically in mammary epithelial cells.
These data provide evidence that leptin, with its receptors, could
be an important mediator in regulating mammary gland growth
and development.
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1. Introduction
Mammary gland development begins during fetal life, in-
creases through puberty and terminates at the end of preg-
nancy. During all phases of development, the mammary epi-
thelium is situated adjacent to stroma, which consists of a
matrix of adipose and ¢brous connective tissue called the
‘mammary fat pad’ [1]. The mammary fat pad was once con-
sidered as an inert matrix, but more recent evidence empha-
sizes the in£uence of adipocyte-epithelial interactions as being
critical for mammary duct growth and morphogenesis [2^6].
Locally produced growth factors are believed to mediate the
adipocyte-epithelial interactions and alter the actions of sev-
eral steroid and peptide hormones on these tissues [7,8].
Leptin, a circulating hormone secreted by adipose tissue [9],
is a cytokine that is capable of in£uencing the growth of
various cell types [10,11]. Furthermore, leptin is expressed in
parametrial adipose tissue and epithelial cells of mouse mam-
mary glands [12]. Consequently, leptin may have both auto-
crine and paracrine actions in the mammary gland. We hy-
pothesized that leptin plays an important physiological role in
mammary epithelial cell growth by acting as a local factor
which mediates adipocyte-epithelial cell interactions.
Leptin acts through single membrane receptors that have
strong sequence homology to the class I cytokine receptor
family [13]. Although multiple isoforms of leptin receptors
have been described, they are generally categorized according
to the length of their intracellular domains as long and short
forms. In order to examine leptin’s potential involvement as a
local factor mediating the interaction between mammary
gland adipocytes and epithelial cells, we used reverse tran-
scription and polymerase chain reaction (RT-PCR) analysis
to identify the expression of long and short form leptin re-
ceptor transcripts in ovine mammary glands. Furthermore, we
used ribonuclease protection assay procedures to determine if
leptin receptor mRNA was di¡erentially expressed during
pregnancy and lactation in mammary glands and we used in
situ hybridization procedures to determine the cell types ex-
pressing the leptin receptor transcripts.
2. Material and methods
2.1. Tissue samples
Animal care and use procedures were approved by the French Min-
istry of Agriculture in adherence with French regulations for animal
experimentation (guideline 19/04/1988). Mammary gland tissue was
collected from three primiparous Pre¤alpes du Sud ewes at each of
the days 15, 50, 70, 106, 112 and 141 of pregnancy and days 3 and
48 of lactation.
2.2. RT-PCR analysis
Total tissue sample RNA was prepared by the guanidium isothio-
cyanate/phenol method, as described by Puissant and Houdebine [14].
The reverse transcription reaction was performed using 2 Wg of total
RNA, with 100 U Superscript II reverse transcriptase (Gibco BRL-
Life Technologies) and 650 ng random primers in a ¢nal volume of 20
Wl, for 50 min at 42‡C. One Wl of each reverse transcription reaction
product was ampli¢ed by PCR in a ¢nal volume of 50 Wl with 200 WM
of each deoxynucleotide triphosphate (Pharmacia LKB Biotechnol-
ogy, France), 45 pmol of each primer (Genset, Paris, France), 2.5 U
Taq Polymerase (Oncor-Appligene, Illkirch, France) and 1UPCR
bu¡er (Oncor-Appligene). Ampli¢cations were performed using a Per-
kin-Elmer Thermocycler replicating for 30 cycles in the following
sequence: denaturation at 94‡C for 1 min, annealing at 55‡C (long
form ovine leptin receptor) or at 52‡C (short form ovine leptin recep-
tor) for 1 min, extension at 72‡C for 1 min and a ¢nal extension step
at 72‡C for 10 min. To amplify the long and short forms of the ovine
leptin receptors, human oligonucleotide primers were chosen accord-
ing to the published human cDNA sequences [13,15]: antisense primer
5P-CAAAAGCACACCACTCTCTC-3P and sense primer 5P-CCA-
GAAACGTTTCAGCATCT-3P speci¢c for the long form of the hu-
man leptin receptor or antisense primer 5P-TCAAAGAATGTCCGT-
TCT-3P and sense primer 5P-GAGAAGTACCAGTTCAGT-3P for the
short form of the human leptin receptor. The expected sizes of the
ampli¢ed fragments were respectively 609 bp (long form) and 279 bp
(short form).
2.3. Analysis of the ampli¢cation products
Speci¢city of the ampli¢ed PCR products was con¢rmed by South-
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ern blot analysis using ovine and human leptin receptor cDNA
probes, which speci¢cally recognized the long and the short forms
of ovine leptin receptor. PCR products were separated on a 2% agar-
ose gel and blotted onto a nylon membrane. The blot was hybridized
with K-32P-labelled probes (3U106 cpm/ml; Amersham, Les Ulis,
France). The ovine leptin receptor probe consisted of 365 bp [16]
and the human leptin receptor probe consisted of 156 bp (nucleotides
2448^2604) nucleotides [13], which recognized the long and short
forms of the ovine leptin receptors, respectively.
Ampli¢cation products were extracted from agarose gel using a
DNA puri¢cation kit (Quiagen, France) and cloned into the
pGEM-T vector, according to the manufacturer’s instructions (Prom-
ega, Lyon, France). The cDNA inserts were then sequenced by auto-
mated DNA sequencing (Applied Bio Systems, Foster City, CA,
USA).
2.4. Ribonuclease protection assay and in situ hybridization
Ribonuclease protection assay and in situ hybridization procedures
were performed as described [17] using antisense and sense RNA
probes. These riboprobes were transcribed using T7 or T3 RNA po-
lymerase (Gibco BRL-Life Technologies, Cergy Pontoise, France) and
labelled with [K-32P]UTP for ribonuclease protection assay (800 Ci/
mmol; Amersham, Les Ulis, France) or [K-35S]UTP for in situ hybrid-
ization (1000 Ci/mmol; Amersham). Antisense riboprobes were pro-
duced using linearized recombinant Bluescript SK (3) transcription
vector (Stratagene, Ozyme, Montigny-le-Bretonneux, France) contain-
ing a 484 bp cDNA fragment of the ovine leptin receptor [16]. This
antisense riboprobe hybridizes with long and short forms of the ovine
leptin receptor. Recombinant pGEM-T transcription vector contain-
ing a cDNA fragment (365 bp) speci¢c for the long form of the ovine
leptin receptor [16] was also linearized and radiolabelled. Labelled
sense probes were used as negative controls for in situ hybridization.
Bands appearing on the autoradiographs were scanned with a
STORM-860 machine (Molecular Dynamics, Bondou£e, France)
and quanti¢ed with ImageQuaNT software (IQNT-130; Molecular
Dynamics). To control for RNA loading di¡erences, ovine leptin re-
ceptor mRNA expression was standardized to ovine glyceraldehyde-3-
phosphate dehydrogenase hybridization signal and the data are pre-
sented as corrected values.
3. Results
3.1. Detection of long and short forms of the leptin receptor in
ovine mammary gland
Expression of the long (Fig. 1A) and short forms (Fig. 1B)
of the ovine leptin receptor was detected in tissues from each
stage of pregnancy and lactation that was examined, as deter-
mined by Southern blot analysis of RT-PCR products hybrid-
ized with leptin receptor probe corresponding to the long
and short form. Subsequent sequencing of the 609 bp frag-
ment revealed 100% identity to the published sequence of the
long form of the ovine leptin receptor [13]. Moreover, the
sequencing of the 279 bp fragment revealed 83% identity to
the short form of the human leptin receptor [15].
3.2. Temporal expression of leptin receptor mRNA in ovine
mammary glands during pregnancy and lactation
Expression of leptin receptor mRNA by mammary gland
tissue collected from three ewes each on days 15, 50, 70, 112
and 141 of pregnancy (P) and days 3 and 48 of lactation (L)
was quanti¢ed via a ribonuclease protection assay utilizing the
484 bp probe which recognizes the long and short forms of
the ovine leptin receptor. The results are illustrated in Fig. 2
and are presented relative to the expression of ovine glycer-
aldehyde-3-phosphate dehydrogenase mRNA. Expression of
ovine leptin receptors was greater during mid-pregnancy
(days 70 and 106) than at any other time tissues were sampled.
In an e¡ort to more precisely de¢ne the leptin receptor form
(short vs. long) that changed during pregnancy and lactation,
we hybridized total RNA from each sample with the 365 bp
probe that was speci¢c for the long form of the ovine leptin
receptor. No hybridization signal was detected (data not
shown), indicating that the short form of the ovine leptin
receptor was predominantly expressed. Moreover, these data
provide evidence that the short form of the ovine leptin re-
ceptor was di¡erentially expressed during pregnancy and lac-
tation.
3.3. Cellular localization of leptin receptor mRNA in ovine
mammary gland
In order to determine which cells in the mammary gland
expressed the leptin receptor gene, in situ hybridization was
performed using the 484 bp cRNA probe that recognized both
the long and short forms of the ovine leptin receptor. In
cryostat sections of mammary gland collected across the var-
ious stages of pregnancy and lactation, we observed leptin
receptor mRNA expression localized within the alveolar epi-
thelial cells (Fig. 3). Moreover, in situ hybridization analysis
provided a con¢rmation of the temporal variation in leptin
receptor mRNA expression throughout pregnancy and lacta-
tion as observed via the ribonuclease protection assay analy-
sis. Indeed, leptin receptor mRNA expression was greatest at
day 70 of pregnancy (A,B), decreased to day 112 of pregnancy
(C,D) and remained detectable during lactation (G and
H = day 3 of lactation). Control tissue sections treated with
the sense probe (E,F) exhibited no speci¢c signal, further
demonstrating the speci¢city of the reaction.
4. Discussion
We report here the ¢rst evidence, obtained via the use of
RT-PCR procedures, that long and short forms of leptin re-
ceptor are expressed in ovine mammary tissue during preg-
nancy and lactation. However, when we utilized ribonuclease
protection assay techniques, which are less sensitive, to quan-
tify the relative abundance of the long and short forms of the
leptin receptors, only the short form of the leptin receptor was
detected. These observations are consistent with the reports of
Tartaglia [13], Mercer [18], Ghilardi [19] and Hoggard [20]
Fig. 1. Detection of the long (A) and short (B) forms of ovine lep-
tin receptor by Southern blot analysis of RT-PCR products in ovine
mammary gland during pregnancy and lactation.
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where further evidence can be found that the long form of the
leptin receptor was expressed at low levels in peripheral tissues
and at high levels in the brain.
We also report here that transcripts of the short forms of
the leptin receptor, as determined via ribonuclease protection
assay, was in greatest abundance in the ovine mammary gland
during mid-pregnancy (days 70^106) and lowest at the end of
pregnancy and during lactation. Furthermore, in situ hybrid-
ization analysis of these tissues reinforced this di¡erential pat-
tern of leptin receptor transcript expression and moreover
localized the leptin receptor transcripts to the mammary al-
veolar epithelial cells. The abundant expression of the leptin
receptor transcript within the mammary epithelial cells at day
70 of pregnancy coincides with the initiation of mammary
epithelial cell proliferation which occurs, as growth of the
mammary gland begins, during mid-pregnancy in the ewe
[21]. Concomitant with this stage of pregnancy and mammary
development, peripheral concentrations of oestradiol are in-
creasing and may contribute to the variation in the expression
of the leptin receptor transcripts [21].
In concert with the leptin receptor dynamics occurring in
the alveolar epithelial cells, we suggest that coincident expres-
sion and regulation of leptin mRNA may also be occurring
within the epithelial cells and parametrial adipose tissues, as
was reported to occur in the mouse mammary gland [22]. In
the present study, utilizing Northern blot procedures, we de-
tected leptin transcripts in the adipose tissue of the ovine
mammary gland (data not shown). This ¢nding is crucial, as
the stromal-epithelial interactions are fundamental for mam-
mary gland growth and development. Indeed, each stage of
mammary glandular development, from ductal branching
through terminal end bud development, alveolar formation
and milk production, is dependent on the presence of the
mammary fat pad [2^6]. Our ¢ndings provide evidence to
support the hypothesis that leptin might be a local growth
factor, which acts as a functional link between adipocytes
and epithelial cells of the mammary gland. By acting as an
autocrine or paracrine factor in the epithelial cell, leptin may
play an important role in the modulation of the mammary
gland growth. This hypothesis is further supported by several
reports which indicate that leptin is a cytokine that is capable
of in£uencing the growth or apoptosis of various cell types
[10,11].
Adipocyte-epithelial interactions are critical in determining
the pattern of ductal growth and morphogenesis in the mam-
mary gland via the e¡ect of local growth factors. These local
factors are implicated as paracrine mediators of several ste-
roids and peptides [7,8]. The ovarian steroids, oestrogen and
progesterone, play an essential role in the development of the
mammary gland during pregnancy. By in vivo and in vitro
studies, it was demonstrated that the mammogenic e¡ects of
oestrogen occur indirectly via epithelial proliferation and mor-
phogenesis and require the cooperative action of mammary
stromal ¢broblasts and adipocytes [23^25]. Moreover, it has
Fig. 2. (A) Detection, by ribonuclease protection assay, of ovine leptin receptor (OB-R) mRNA in ewe mammary tissue at various stages of
pregnancy and lactation. The radiolabelled 484 bp leptin receptor fragment, used as the cRNA probe, was hybridized to 10 Wg of mammary
gland total RNA. As controls, the leptin receptor cRNA probe was hybridized with yeast tRNA and then treated with RNase (C2) or not
(C1). (B) Determination, from STORM scanning of the ribonuclease protection assay gels, of the ovine leptin receptor mRNA to ovine glycer-
aldehyde-3-phosphate dehydrogenase (oGAPDH) mRNA.
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been reported that oestrogen receptors are present on mam-
mary ¢broblasts and adipocytes [26,27]. Several reports have
described that leptin expression is induced by oestradiol in
adipocyte [28,29].
In conclusion, leptin is ideally suited as a potentially im-
portant downstream mediator of steroid action, acting locally
to regulate mammary gland growth and development via adi-
pocyte-epithelial interactions. The data we present here pro-
vide evidence that indeed leptin is produced by the mammary
gland fat pad and receptors for leptin exist on mammary
alveoli epithelial cells. Furthermore, the expression of the lep-
tin receptor gene increases during mid-pregnancy, coincident
with the initiation of mammary development and rising pe-
ripheral concentrations of oestradiol.
Fig. 3. In situ hybridization analysis of ovine leptin receptor mRNA expression in the ovine mammary gland at day 70 (A,B) and 112 (C,D) of
pregnancy and day 3 of lactation (E,F). A section of the mammary gland at day 70 of pregnancy (G,H) was hybridized with the sense probe
and used as a control of speci¢city. The right and left column correspond to bright-¢eld and epi-illuminated photomicrographs. Bar = 39 Wm.
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